These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The combined use of alphavirus replicons and pseudoinfectious particles for the discovery of antivirals derived from natural products. Delekta PC, Raveh A, Larsen MJ, Schultz PJ, Tamayo-Castillo G, Sherman DH, Miller DJ. J Biomol Screen; 2015 Jun; 20(5):673-80. PubMed ID: 25550354 [Abstract] [Full Text] [Related]
24. Alphavirus Nucleocapsid Packaging and Assembly. Mendes A, Kuhn RJ. Viruses; 2018 Mar 20; 10(3):. PubMed ID: 29558394 [Abstract] [Full Text] [Related]
25. Posaconazole inhibits multiple steps of the alphavirus replication cycle. Varghese FS, Meutiawati F, Teppor M, Jacobs S, de Keyzer C, Taşköprü E, van Woudenbergh E, Overheul GJ, Bouma E, Smit JM, Delang L, Merits A, van Rij RP. Antiviral Res; 2022 Jan 20; 197():105223. PubMed ID: 34856248 [Abstract] [Full Text] [Related]
28. β-d-N4-Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome. Urakova N, Kuznetsova V, Crossman DK, Sokratian A, Guthrie DB, Kolykhalov AA, Lockwood MA, Natchus MG, Crowley MR, Painter GR, Frolova EI, Frolov I. J Virol; 2018 Feb 01; 92(3):. PubMed ID: 29167335 [Abstract] [Full Text] [Related]
30. Characterization of the mode of action of a potent dengue virus capsid inhibitor. Scaturro P, Trist IM, Paul D, Kumar A, Acosta EG, Byrd CM, Jordan R, Brancale A, Bartenschlager R. J Virol; 2014 Oct 01; 88(19):11540-55. PubMed ID: 25056895 [Abstract] [Full Text] [Related]
31. Imaging the alphavirus exit pathway. Martinez MG, Snapp EL, Perumal GS, Macaluso FP, Kielian M. J Virol; 2014 Jun 01; 88(12):6922-33. PubMed ID: 24696489 [Abstract] [Full Text] [Related]
35. Imaging of the alphavirus capsid protein during virus replication. Zheng Y, Kielian M. J Virol; 2013 Sep 01; 87(17):9579-89. PubMed ID: 23785213 [Abstract] [Full Text] [Related]
37. Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms. Ho YJ, Liu FC, Yeh CT, Yang CM, Lin CC, Lin TY, Hsieh PS, Hu MK, Gong Z, Lu JW. Antiviral Res; 2018 Nov 01; 159():134-142. PubMed ID: 30300716 [Abstract] [Full Text] [Related]
38. Mutations in the Basic Region of the Mason-Pfizer Monkey Virus Nucleocapsid Protein Affect Reverse Transcription, Genomic RNA Packaging, and the Virus Assembly Site. Dostálková A, Kaufman F, Křížová I, Kultová A, Strohalmová K, Hadravová R, Ruml T, Rumlová M. J Virol; 2018 May 15; 92(10):. PubMed ID: 29491167 [Abstract] [Full Text] [Related]
39. Targeting the alphavirus virus replication process for antiviral development. Tan YB, Law MCY, Luo D. Antiviral Res; 2023 Feb 15; 210():105494. PubMed ID: 36574906 [Abstract] [Full Text] [Related]
40. Alphavirus nucleocapsid protein contains a putative coiled coil alpha-helix important for core assembly. Perera R, Owen KE, Tellinghuisen TL, Gorbalenya AE, Kuhn RJ. J Virol; 2001 Jan 15; 75(1):1-10. PubMed ID: 11119567 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]